These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. TREATMENT OF DEPRESSION. PARE CM. Lancet; 1965 May 01; 1(7392):923-5. PubMed ID: 14275707 [No Abstract] [Full Text] [Related]
23. [Enzymatic method for the detection of monoamine oxidase inhibitors]. Mercier MJ, Curry AS. Eur J Toxicol; 1971 May 01; 4(1):36-8. PubMed ID: 5092664 [No Abstract] [Full Text] [Related]
24. The behavioral toxicity of monoamine oxidase-inhibiting antidepressants. Murphy DL. Adv Pharmacol Chemother; 1977 May 01; 14():71-105. PubMed ID: 18913 [No Abstract] [Full Text] [Related]
25. ANTI-DEPRESSANT DRUGS. JACKSON D, BERNARD LA, BENTLIF P. Med Rec Ann; 1963 Oct 01; 56():216-8 PASSIM. PubMed ID: 14053455 [No Abstract] [Full Text] [Related]
26. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method. Bartonícek V. Med Pharmacol Exp Int J Exp Med; 1967 Oct 01; 16(2):142-6. PubMed ID: 5298397 [No Abstract] [Full Text] [Related]
27. Monoamine oxidase inhibitors: nature of their interaction with rabbit pancreatic islets to alter insluin secretion. Feldman JM, Chapman B. Diabetologia; 1975 Dec 01; 11(6):487-94. PubMed ID: 1107123 [Abstract] [Full Text] [Related]
28. Evidence that a preferred substrate for type B monoamine oxidase mediates stimulus properties of MAO inhibitors: a possible role for beta-phenylethylamine in the cocaine cue. Colpaert FC, Niemegeers CJ, Janssen PA. Pharmacol Biochem Behav; 1980 Oct 01; 13(4):513-7. PubMed ID: 6107935 [Abstract] [Full Text] [Related]
29. SYMPATHOMIMETIC ACTIONS OF MONOAMINE OXIDASE INHIBITORS IN THE ISOLATING NICITATING MEMBRANE OF THE CAT. TSAI TH, FLEMING WW. Biochem Pharmacol; 1965 Mar 01; 14():369-71. PubMed ID: 14314337 [No Abstract] [Full Text] [Related]
30. [The effect of dopamine and MAO inhibitors on centrally stimulated vomiting]. Förster W, Gräbner S. Acta Biol Med Ger; 1966 Mar 01; 16(6):650-7. PubMed ID: 4383660 [No Abstract] [Full Text] [Related]
33. [ELECTROENCEPHALOGRAPHIC CONTRIBUTION TO THE STUDY OF MONOAMINE OXIDASE INHIBITING DRUGS: CHANGES INDUCED IN EXPERIMENTAL EPILEPSY IN RABBITS]. LUCIONI R, PENATI G, INVERNIZZI G. Riv Neurol; 1964 Mar 01; 34():368-74. PubMed ID: 14208879 [No Abstract] [Full Text] [Related]
34. Special application of fluorescence histochemistry: studies on eight monoamine oxidase inhibitors in brain neurons. Bartonícek VJ. Pharmacology; 1970 Mar 01; 4(1):16-24. PubMed ID: 4393462 [No Abstract] [Full Text] [Related]
35. CURRENT STATUS OF DRUG TREATMENT IN THE DEPRESSIVE STATE. SIEGLER PE. Med Clin North Am; 1964 Mar 01; 48():483-500. PubMed ID: 14149246 [No Abstract] [Full Text] [Related]
36. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors. Alemany R, Olmos G, García-Sevilla JA. Br J Pharmacol; 1995 Feb 01; 114(4):837-45. PubMed ID: 7773544 [Abstract] [Full Text] [Related]
37. [Effect of monoamine oxidase inhibitors on the tryptamine content of the rat brain and on "tryptamine convulsions"]. Popov N, Lietz W, Matthies H. Acta Biol Med Ger; 1967 Feb 01; 18(2):233-44. PubMed ID: 5586804 [No Abstract] [Full Text] [Related]
38. Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors. Fagervall I, Ross SB. Biochem Pharmacol; 1986 Apr 15; 35(8):1381-7. PubMed ID: 2870717 [Abstract] [Full Text] [Related]
39. THE PRACTICAL MANAGEMENT OF DEPRESSION. KLINE NS. JAMA; 1964 Nov 23; 190():732-40. PubMed ID: 14201588 [No Abstract] [Full Text] [Related]
40. 2-SUBSTITUTED CYCLOPROPYLAMINES. II. EFFECT OF STRUCTURE UPON MONOAMINE OXIDASE-INHIBITORY ACTIVITY AS MEASURED IN VIVO BY POTENTIATION OF TRYPTAMINE CONVULSIONS. ZIRKLE CL, KAISER C, TEDESCHI DH, TEDESCHI RE, BURGER A. J Med Pharm Chem; 1962 Nov 23; 5():1265-84. PubMed ID: 14056459 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]